from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1731/gabD2

LFCtreatmentdescriptionclass of inhibitor

0.460

Amikacinug/mL Amikacintranslation

0.220

Cap5-10ug/mL Capreomycintranslation

-0.456

Rox10-50 ug/mL Roxithromycintranslation

0.539

SM2-5 ug/mL Streptomycintranslation

-0.842

Tet5-10 ug/mL Tetracyclinetranslation

0.885

Rif0.2-5ug/mL Rifampicintranscription

-0.024

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.301

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.437

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.117

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.259

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.936

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.669

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.136

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.137

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.943

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.099

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.249

KCN5-20 ug/mL Potassium cyaniderespiration

-0.478

NaN30.2-2 mM Sodium aziderespiration

-1.414

Nigericin50 uM Nigericinrespiration

0.305

TRC10-150 ug/mL Triclosanrespiration

2.124

TRZ10-25 ug/mL Thioridazinerespiration

0.294

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.888

menadione6-10 ug/mL Menadionerespiration

-0.539

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.424

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.571

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.306

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.732

NRP_1Non-replicating persistence stage 1dosRassociated

-0.133

Amp0.2mg/mL AmpicillincellWall

1.236

Cephalexin20-100 ug/mL CephalexincellWall

-0.070

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.218

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.076

EMB10-20 ug/mL EthambutolcellWall

0.011

Eta12-40 ug/mL EthionamidecellWall

0.180

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.401

TLM0.1-0.2 mg/mL ThiolactomycincellWall

2.039

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.350

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.205

BZA0.12 mg/mL BenzamidearomaticAmides

-0.462

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.123

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.321

H2O24 mM hydrogen peroxideDNAdamaging

-0.623

Levo10 ug/mL LevofloxacinDNAdamaging

-0.673

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.644

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.372

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.462

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.271

Antimycin12.5-50 ug/mL Antimycin A?

-1.500

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.691

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.451

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.116

PA8240.2-2 ug/mL PA-824?

-0.154

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.491

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-1.514

mercaptoethanol2 mM 2-Mercaptoethanol?

2.642

methoxatin10-20 ug/mL Methoxatin?